Raymond Debbane - 13 May 2025 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Raymond Debbane
Issuer symbol
LXRX
Transactions as of
13 May 2025
Net transactions value
$0
Form type
4
Filing time
13 May 2025, 17:48:38 UTC
Previous filing
13 May 2024
Next filing
03 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DEBBANE RAYMOND Director 2445 TECHNOLOGY FOREST BLVD., 11TH FLOOR, THE WOODLANDS /s/ Raymond Debbane 13 May 2025 0001053890

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise $0 +36,810 +2.7% $0.000000 1,385,689 13 May 2025 Direct
holding LXRX Common Stock 44,370,107 13 May 2025 By Invus L.P., Invus Public Equities L.P., Invus US Partners LLC and related parties

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise $0 -36,810 -100% $0.000000 0 13 May 2025 Common Stock 36,810 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.